ATE488229T1 - Transdermale verabreichung eines meptazinolsalzes - Google Patents
Transdermale verabreichung eines meptazinolsalzesInfo
- Publication number
- ATE488229T1 ATE488229T1 AT06848981T AT06848981T ATE488229T1 AT E488229 T1 ATE488229 T1 AT E488229T1 AT 06848981 T AT06848981 T AT 06848981T AT 06848981 T AT06848981 T AT 06848981T AT E488229 T1 ATE488229 T1 AT E488229T1
- Authority
- AT
- Austria
- Prior art keywords
- meptazinol
- salt
- transdermal administration
- transdermal
- administration
- Prior art date
Links
- JLICHNCFTLFZJN-HNNXBMFYSA-N meptazinol Chemical class C=1C=CC(O)=CC=1[C@@]1(CC)CCCCN(C)C1 JLICHNCFTLFZJN-HNNXBMFYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75335705P | 2005-12-21 | 2005-12-21 | |
| US86211406P | 2006-10-19 | 2006-10-19 | |
| PCT/US2006/048783 WO2007075883A2 (en) | 2005-12-21 | 2006-12-21 | Transdermal delivery of meptazinol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE488229T1 true ATE488229T1 (de) | 2010-12-15 |
Family
ID=38198475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06848981T ATE488229T1 (de) | 2005-12-21 | 2006-12-21 | Transdermale verabreichung eines meptazinolsalzes |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070224253A1 (de) |
| EP (1) | EP1962817B1 (de) |
| AR (1) | AR058598A1 (de) |
| AT (1) | ATE488229T1 (de) |
| AU (1) | AU2006331596A1 (de) |
| CA (1) | CA2633369A1 (de) |
| DE (1) | DE602006018355D1 (de) |
| DK (1) | DK1962817T3 (de) |
| EA (1) | EA200801575A1 (de) |
| MX (1) | MX2008008050A (de) |
| PE (1) | PE20071163A1 (de) |
| PT (1) | PT1962817E (de) |
| TW (1) | TW200800223A (de) |
| UY (1) | UY30056A1 (de) |
| WO (1) | WO2007075883A2 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090280064A1 (en) * | 2005-06-24 | 2009-11-12 | Rao Papineni | Transdermal delivery of optical, spect, multimodal, drug or biological cargo laden nanoparticle(s) in small animals or humans |
| CA2657435A1 (en) | 2006-07-10 | 2008-07-03 | Medipacs, Inc. | Super elastic epoxy hydrogel |
| US9995295B2 (en) | 2007-12-03 | 2018-06-12 | Medipacs, Inc. | Fluid metering device |
| WO2009092073A2 (en) * | 2008-01-18 | 2009-07-23 | Shire Llc | Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| CN102159205A (zh) * | 2008-06-25 | 2011-08-17 | Fe3医学有限公司 | 用于经皮递送治疗有效量的铁的贴片和方法 |
| US8348922B2 (en) * | 2009-02-12 | 2013-01-08 | Incube Labs, Llc | Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent |
| US8961492B2 (en) | 2009-02-12 | 2015-02-24 | Incube Labs, Llc | System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation |
| US8190252B2 (en) | 2009-02-12 | 2012-05-29 | Incube Labs, Llc | Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes |
| US8821945B2 (en) * | 2009-04-25 | 2014-09-02 | Fe3 Medical, Inc. | Method for transdermal iontophoretic delivery of chelated agents |
| WO2010151845A2 (en) * | 2009-06-26 | 2010-12-29 | Incube Labs, Llc | Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use |
| US8903485B2 (en) * | 2009-08-06 | 2014-12-02 | Incube Labs, Llc | Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes |
| WO2011032011A1 (en) | 2009-09-10 | 2011-03-17 | Medipacs, Inc. | Low profile actuator and improved method of caregiver controlled administration of therapeutics |
| US8685038B2 (en) | 2009-12-07 | 2014-04-01 | Incube Labs, Llc | Iontophoretic apparatus and method for marking of the skin |
| US9500186B2 (en) | 2010-02-01 | 2016-11-22 | Medipacs, Inc. | High surface area polymer actuator with gas mitigating components |
| WO2011094814A1 (en) | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| WO2011100376A2 (en) | 2010-02-10 | 2011-08-18 | Incube Labs, Llc | Methods and architecture for power optimization of iontophoretic transdermal drug delivery |
| CA2794734C (en) | 2010-03-30 | 2017-12-12 | Phosphagenics Limited | Transdermal delivery patch |
| US8668675B2 (en) | 2010-11-03 | 2014-03-11 | Flugen, Inc. | Wearable drug delivery device having spring drive and sliding actuation mechanism |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| AU2012230701B2 (en) | 2011-03-24 | 2016-09-29 | Incube Labs, Llc | System and method for biphasic transdermal iontophoretic delivery of therapeutic agents |
| WO2012154704A2 (en) | 2011-05-06 | 2012-11-15 | Incube Labs, Llc | System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings |
| US8636696B2 (en) | 2011-06-10 | 2014-01-28 | Kimberly-Clark Worldwide, Inc. | Transdermal device containing microneedles |
| JP2015510956A (ja) | 2012-03-14 | 2015-04-13 | メディパックス インコーポレイテッド | 過剰反応性分子を含むスマートポリマー材料 |
| US9861801B2 (en) | 2013-02-28 | 2018-01-09 | Kimberly-Clark Worldwide, Inc. | Drug delivery device |
| RU2622605C2 (ru) | 2013-02-28 | 2017-06-16 | Кимберли-Кларк Ворлдвайд, Инк. | Устройство трансдермальной доставки лекарств |
| US10376308B2 (en) | 2015-02-05 | 2019-08-13 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure by splanchnic nerve ablation |
| US10973761B2 (en) | 2015-12-09 | 2021-04-13 | Phosphagenics Limited | Pharmaceutical formulation |
| EP3490442A4 (de) | 2016-07-29 | 2020-03-25 | Axon Therapies, Inc. | Vorrichtungen, systeme und verfahren zur behandlung von herzinsuffizienz mittels splanchnikusnervenablation |
| JP7198754B2 (ja) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | 方法 |
| US10561461B2 (en) | 2017-12-17 | 2020-02-18 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
| EP4721783A3 (de) | 2018-01-26 | 2026-06-17 | Axon Vascular, Inc. | Verfahren und vorrichtungen zur endovaskulären ablation eines splanchnischen nervs |
| EP4241836B8 (de) | 2019-06-20 | 2025-04-02 | Axon Vascular, Inc. | Vorrichtungen zur endovaskulären ablation eines splanchnischen nervs |
| CN121313303A (zh) | 2020-01-17 | 2026-01-13 | 阿克松血管公司 | 用于内脏神经的血管内消融的方法和装置 |
| CN113491675B (zh) * | 2021-07-01 | 2023-05-23 | 北京航空航天大学 | 一种预防瘢痕的微针创口贴及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1539277A (en) * | 1977-09-16 | 1979-01-31 | Wyeth John & Brother Ltd | Hexahydro-1h-azepines |
| IE55189B1 (en) * | 1982-07-08 | 1990-06-20 | Wyeth John & Brother Ltd | Pharmaceutical compositions |
| IE60941B1 (en) * | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
| US6916486B2 (en) * | 1996-02-19 | 2005-07-12 | Acrux Dds Pty Ltd | Transdermal delivery of analgesics |
| JP2002519366A (ja) * | 1998-07-07 | 2002-07-02 | トランスダーマル・テクノロジーズ・インコーポレーテツド | 医薬的に活性な作用物質を迅速かつ非刺激的に経皮送達するための組成物、およびそのような組成物の調剤法およびそれらの送達 |
| US6716449B2 (en) * | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
| DE10059415A1 (de) * | 2000-11-30 | 2002-06-06 | Gruenenthal Gmbh | Verwendung von schwachen Opioiden und gemischten Opioidagonisten/-antagonisten zur Therapie der Harninkontinenz |
| ES2323127T3 (es) * | 2002-08-20 | 2009-07-07 | Euro-Celtique S.A. | Forma posologica transdermica que comprende un agente activo y una forma de sal y una forma de base libre de un antagonista. |
| BRPI0409945A (pt) * | 2003-04-30 | 2006-04-25 | Purdue Pharma Lp | forma de dosagem resistente à alteração |
-
2006
- 2006-12-20 TW TW095147948A patent/TW200800223A/zh unknown
- 2006-12-21 DE DE602006018355T patent/DE602006018355D1/de active Active
- 2006-12-21 EA EA200801575A patent/EA200801575A1/ru unknown
- 2006-12-21 MX MX2008008050A patent/MX2008008050A/es unknown
- 2006-12-21 DK DK06848981.4T patent/DK1962817T3/da active
- 2006-12-21 US US11/614,165 patent/US20070224253A1/en not_active Abandoned
- 2006-12-21 PE PE2006001676A patent/PE20071163A1/es not_active Application Discontinuation
- 2006-12-21 AR ARP060105700A patent/AR058598A1/es unknown
- 2006-12-21 AT AT06848981T patent/ATE488229T1/de active
- 2006-12-21 CA CA002633369A patent/CA2633369A1/en not_active Abandoned
- 2006-12-21 UY UY30056A patent/UY30056A1/es not_active Application Discontinuation
- 2006-12-21 PT PT06848981T patent/PT1962817E/pt unknown
- 2006-12-21 EP EP06848981A patent/EP1962817B1/de not_active Not-in-force
- 2006-12-21 WO PCT/US2006/048783 patent/WO2007075883A2/en not_active Ceased
- 2006-12-21 AU AU2006331596A patent/AU2006331596A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006331596A1 (en) | 2007-07-05 |
| WO2007075883A2 (en) | 2007-07-05 |
| EP1962817A2 (de) | 2008-09-03 |
| TW200800223A (en) | 2008-01-01 |
| DE602006018355D1 (de) | 2010-12-30 |
| DK1962817T3 (da) | 2011-03-07 |
| US20070224253A1 (en) | 2007-09-27 |
| WO2007075883A9 (en) | 2007-08-23 |
| UY30056A1 (es) | 2007-06-29 |
| EP1962817B1 (de) | 2010-11-17 |
| WO2007075883A3 (en) | 2008-01-17 |
| EA200801575A1 (ru) | 2008-12-30 |
| PE20071163A1 (es) | 2007-11-30 |
| PT1962817E (pt) | 2010-12-13 |
| MX2008008050A (es) | 2009-04-06 |
| AR058598A1 (es) | 2008-02-13 |
| CA2633369A1 (en) | 2007-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006018355D1 (de) | Transdermale verabreichung eines meptazinolsalzes | |
| NL301209I1 (nl) | capmatinib of een farmaceutisch aanvaardbaar zout daarvan | |
| NL301106I2 (nl) | Cenobamaat of een farmaceutisch aanvaardbaar zout daarvan | |
| FIC20240046I1 (fi) | Vibegroni tai sen farmaseuttisesti hyväksyttävä suola | |
| NL301003I2 (nl) | Sotagliflozin of een farmaceutisch aanvaardbaar zout daarvan | |
| NL300993I2 (nl) | Apalutamide of een farmaceutisch aanvaardbaar zout daarvan | |
| FIC20230039I1 (fi) | Sedatsuridiini tai tämän farmaseuttisesti hyväksyttävä suola | |
| NL301166I2 (nl) | Avacopan of een farmaceutisch aanvaardbaar zout daarvan | |
| FIC20253002I1 (fi) | Otsanimodi, tai sen farmaseuttisesti hyväksyttävä suola, mukaan lukien hydrokloridisuola | |
| NL301071I2 (nl) | alpelisib of een farmaceutisch aanvaardbaar zout ervan | |
| FIC20240007I1 (fi) | Gefapiksantti tai sen farmaseuttisesti hyväksyttävä suola | |
| FIC20250005I1 (fi) | Irinotekaanisukrosofaattisuola | |
| FIC20240039I1 (fi) | Kapivasertibi, valinnaisesti farmaseuttisesti hyväksyttävän suolan muodossa | |
| NL350108I2 (nl) | Isofetamid of een zout daarvan | |
| NL301304I2 (nl) | aprocitentan of een farmaceutisch aanvaardbaar zout daarvan | |
| NO2024006I1 (no) | Piflufolastat (18F) or a pharmaceutically acceptable salt thereof | |
| FIC20190029I1 (fi) | Brigatinibi tai sen farmaseuttisesti hyväksyttävä suola | |
| NL301065I2 (nl) | Ozanimod of een farmaceutisch aanvaardbaar zout daarvan, in het bijzonder ozanimodhydrochloride | |
| NL300865I2 (nl) | Eluxadoline of een farmaceutisch aanvaardbaar zout ervan | |
| NO2019027I1 (no) | kobicistat eller et farmasøytisk akseptabelt salt derav | |
| CY2014012I1 (el) | Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης | |
| NL300640I2 (nl) | Alogliptine of een farmaceutisch aanvaardbaar zout daarvan | |
| IL250734A0 (en) | Transdermal therapeutic system | |
| DK2041139T3 (da) | Farmaceutiske forbindelser | |
| EP2376098A4 (de) | Dipeptid-verknüpfte medizinische mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1962817 Country of ref document: EP |